🔎 Trials Near Me

Hjem › Ikke-småcellet lungekreft › California › Huntington Beach

Kliniske studier for Ikke-småcellet lungekreft i Huntington Beach, CA

14 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Huntington Beach (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

RekruttererFase 3
  • City Of Hope - Seacliff /ID# 263143, Huntington Beach
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT04928846

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

RekruttererFase 3
  • Orange Coast Memorial Medical Center, Fountain Valley · 4 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07361510

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

RekruttererFase 3
  • Memorial Care Orange Coast Medical Center Attn, Fountain Valley · 4 mi unna
  • MemorialCare Orange Coast Medical Center, Fountain Valley · 4 mi unna
  • OC Blood and Cancer Care, Fountain Valley · 4 mi unna
  • og 1 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07222566

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

RekruttererFase 3
  • Research Site, Fountain Valley · 4 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06357533

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

RekruttererFase 2/3
  • Local Institution - 007-777, Fountain Valley · 4 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT04613596

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

RekruttererFase 3
  • Orange Coast Memorial Medical Center Fountain Valley, Fountain Valley · 4 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06899126

First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

RekruttererFase 1/2
  • City of Hope, Huntington Beach
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06043817

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

RekruttererFase 2
  • Compassionate Cancer Care Center, Fountain Valley · 4 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 26. aug. 2026 · NCT07288177

A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma

RekruttererFase 2
  • Los Angeles Cancer Network, Fountain Valley · 4 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 4. mai 2026 · NCT05456256

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

RekruttererFase 2
  • City of Hope Seacliff, Huntington Beach
Alder 18 og eldre · Alle kjønn · Oppdatert 15. apr. 2026 · NCT07288034

GEMINI-NSCLC: NSCLC Biomarker Study

RekruttererObservasjonsstudie
  • MemorialCare, Fountain Valley · 4 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 5. feb. 2026 · NCT05236114

Ikke-småcellet lungekreft-studier i andre byer

Andre studier i Huntington Beach

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.